Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Concomitant Fluad and PPV23 in Elderly
NCT02225327Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, pneumococcal infection, sponsored by Korea University Guro Hospital. Started Oct 2013; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenzapneumococcal infection
Beyond the preview
Go deeper on NCT02225327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225327.